A vaccine targeting a broad range of viruses that was designed using Artificial Intelligence had a “modest” effect on immune systems in a small, early trial, according to a new study.The trial marks the first time a vaccine whose active ingredient was entirely designed by AI has been tested in humans, researchers at the University of Cambridge in the UK said on Friday.The experimental jab is intended to be a “universal vaccine” which protects people against a range of viruses that have previously sparked deadly outbreaks including Severe Acute Respiratory Syndrome (Sars), Middle East Respiratory Syndrome (Mers) and COVID-19.
SRCSouth China Morning Post
LANGEN
LEANCenter-Right
WORDS99
ENT6
FRI · 2026-06-05 · 18:12 GMTBRIEF NSR-2026-0605-82102
NSR-2026-0605-82102News Report·EN·Public Health
First AI-designed ‘universal vaccine’ tested in humans
Researchers at the University of Cambridge in the UK have conducted the first human trial of a vaccine entirely designed by artificial intelligence. This experimental jab is intended to be a "universal vaccine" capable of protecting against a range of viruses that have previously caused deadly outbreaks, such as SARS, MERS, and COVID-19.
Agence France-PresseSouth China Morning PostFiled 2026-06-05 · 18:12 GMTLean · Center-RightRead · 1 min
South China Morning PostFIG 01
Reading time
1min
Word count
99words
Sources cited
1cited
Entities identified
6entities
Quality score
100%
§ 01
Briefing Summary
AI-generatedNEWSAR · AI
Researchers at the University of Cambridge in the UK have conducted the first human trial of a vaccine entirely designed by artificial intelligence. This experimental jab is intended to be a "universal vaccine" capable of protecting against a range of viruses that have previously caused deadly outbreaks, such as SARS, MERS, and COVID-19. In this small, early trial, the AI-designed vaccine demonstrated a "modest" effect on immune systems. The study, published on Friday, marks a significant milestone in the application of AI in vaccine development.
Confidence 0.85Sources 1Claims 3Entities 6
§ 02
Article analysis
Model · rule-basedFraming
Public Health
Technology
Tone
Measured
AI-assessed
CalmNeutralAlarmist
Factuality
0.90 / 1.00
Factual
LowHigh
Sources cited
1
Limited
FewMany
§ 03
Key claims
3 extracted01
This trial is the first human test of a vaccine whose active ingredient was entirely designed by AI.
factualUniversity of Cambridge researchers
Confidence
1.00
02
The experimental vaccine aims to protect against viruses like Sars, Mers, and Covid-19.
factual
Confidence
0.90
03
An AI-designed vaccine targeting a broad range of viruses showed a modest effect on immune systems in an early human trial.
factualstudy authors
Confidence
0.90
§ 04
Full report
1 min read · 99 words§ 05
Entities
6 identifiedKey playerOppositionContextPositiveNeutralNegative
Organizations1
Locations1
§ 06
Keywords & salience
9 termsai-designed vaccine
1.00
universal vaccine
0.90
artificial intelligence
0.80
human trials
0.70
viral outbreaks
0.60
immune systems
0.50
sars
0.40
mers
0.40
covid-19
0.40
§ 07
Topic connections
Interactive graph Network visualization showing 51 related topics
View Full Graph Person Organization Location Event|Click node to navigate|Edge numbers = shared articles